AIM

The ICCAC Exchange Award offers U.S., European, Australian, Canadian or Asian mechanical circulatory assist clinicians the opportunity to share information and experience mechanical circulatory support (MCS) patient management on an international level at a partner program. An award of $1800 for each participating VAD Coordinator will be offered to offset travel and accommodation expenses.
 
WHO CAN APPLY?

The ICCAC Exchange Award is addressed to ICCAC members interested in improving their knowledge and to share information in order to achieve optimal outcomes for patients requiring mechanical circulatory support on an international level. ICCAC members interested in caring for MCS patients together with another ICCAC member of a different mechanical circulatory support program are encouraged to apply for this exchange award. MCS clinicians that previously have won this award will not be eligible apply for a second time. Applications that were not selected in previous award selections can re-submit.
 
To ensure optimal knowledge, exchange and activity, both of the participating MCS centers must fulfill the following criteria:
  • Minimum of 20 ongoing MCS patients
  • Minimum of 15 MCS implantations per year
  • Minimum of 5 MCS in-patients during the exchange week
  • At least one MCS outpatient clinic per week
WHERE TO GO AND HOW LONG TO STAY?

The two ICCAC members will belong to one U.S. and one International (e.g. European, Australian, Canadian or Asian) hospital interested in collaborating on MCS patient management and plan to carry out a common short project (either Clinical or Research, see Evaluation Procedure), that can be completed during the exchange program.
 
The ICCAC Exchange consists of two steps: one period in each institution of the two ICCAC colleagues who are submitting the application. The duration of the exchange period will be a minimum of two weeks (one for each hospital). The exchange will be regulated by the host institution (safety, insurance etc.) and the guest MCS clinician must comply with these rules.
 
HOW TO APPLY?

A complete application consists of the following:
  1. Cover page with personal information of the two MCS clinicians involved in the exchange. (see FORM 1)
  2. Exchange proposal written by the two MCS clinicians involved. (see FORM 2)
  3. Curriculum Vitae of the two MCS clinicians.
  4. Letter of support from the MCS Medical Director of the two hosting hospitals.
  5. ICCAC Membership confirmation (if not already a member).
For further information or application, submit all documents to the following email address: thomas.schloeglhofer@meduniwien.ac.at
If one of the requested documents is missing, the application will be excluded from the evaluation procedure.
 
ELIGIBLE COSTS

ICCAC will fund $1800 for each MCS clinician to offset travel and accommodation expenses.

            

EVALUATION PROCEDURE

The application will be evaluated by three reviewers (ICCAC Board Members at Large) that are not working in the two institutions involved in the exchange program. Reviewers will be nominated by the ICCAC Board of Directors.
Each proposal will be evaluated by a score ranging from 0 to 10 (where ten is the highest mark) according to:
  • Quality and Methodology of the Exchange proposal
  • Innovation and originality of the short project
  1. Clinical: e.g. educational lectures, good clinical practice exchange, improvement in patient management, share your experiences in driveline exit site management, etc.
  2. Research: e.g. small joint studies
  • Profile of the applicants and his/her experience as MCS clinician
  • Experience of the participating MCS centers according to number patients ongoing/implants per year
  • Expected Outcomes
 
AFTER THE EXCHANGE

The two MCS clinicians
  • Must provide a summary of the exchange experience as an ICCAC newsletter article.·     
  • May present heir experience at the ICCAC 10th Annual Meeting.
  • It is encouraged to submit an abstract to the ISHLT 2017 Meeting if clinical relevant results or scientific findings arise which could improve MCS patient management.